5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

P Huot, JM Brotchie - Experimental neurology, 2011 - Elsevier
In a recent issue of Experimental Neurology, Dupre et al. report on a study performed in the
6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) which brings …
被引用次数：17 相关文章
[PDF] atuka.com

[PDF][PDF] 5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

P Huota, JM Brotchiea - Experimental Neurology, 2011 - atuka.com
In a recent issue of Experimental Neurology, Dupre et al. report on a study performed in the
6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) which brings …

[引用][C] 5-HT (1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms

P Huot, JM Brotchie - Experimental neurology, 2011 - pubmed.ncbi.nlm.nih.gov
5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease:
bridging the gap between serotonergic and glutamatergic mechanisms 5-HT(1A) receptor …

[引用][C] 5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

P Huot, JM Brotchie - Experimental Neurology, 2011 - infona.pl
5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging
the gap between serotonergic and glutamatergic mechanisms × Close The Infona portal uses …
[PDF] atuka.com

[PDF][PDF] 5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

P Huota, JM Brotchiea - Experimental Neurology, 2011 - atuka.com
In a recent issue of Experimental Neurology, Dupre et al. report on a study performed in the
6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) which brings …

[引用][C] 5-HT (1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms.

P Huot, JM Brotchie - Experimental Neurology, 2011 - europepmc.org
5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease:
bridging the gap between serotonergic and glutamatergic mechanisms. - Abstract - Europe …
[PDF] atuka.com

[PDF][PDF] 5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

P Huota, JM Brotchiea - Experimental Neurology, 2011 - atuka.com
In a recent issue of Experimental Neurology, Dupre et al. report on a study performed in the
6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) which brings …